Suppr超能文献

端粒酶下调诱导促凋亡基因表达,并以细胞类型依赖的方式引发乳腺癌细胞凋亡,随后发生 DNA 片段化。

Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent manner.

机构信息

Department of Clinical Chemistry and Molecular Diagnostics, Poznan University of Medical Sciences, ul. Przybyszewskiego 49, 60-355, Poznan, Poland.

出版信息

Mol Biol Rep. 2013 Aug;40(8):4995-5004. doi: 10.1007/s11033-013-2600-9. Epub 2013 May 16.

Abstract

The aim of the study was to analyze the consequence of silencing genes coding for the key subunits of the telomerase complex, i.e. TERT, TERC and TP1 in human breast cancer MCF7 and MDA-MB-231cells. The transfection was performed using Lipofectamine2000 and pooled siRNAs. The cytotoxic and/or antiproliferative effect of siRNA was measured by the SRB assay, the cell cycle was analysed by flow cytometry and DNA fragmentation by TUNEL analysis. Telomerase activity was assessed by TRAP, followed by PAGE and ELISA assays. Telomerase downregulation was also assessed using qPCR in order to estimate the changes in the expression profile of genes engaged in apoptosis. It was revealed that treatment of breast cancer cells with different siRNAs (100 nM) resulted in a cell type and time-dependent effects. The downregulation of telomerase subunits was followed by reduction of telomerase activity down to almost 60% compared to control cells. However, a significant effect was only observed when the TERT subunit was downregulated. Its silencing resulted in a significant (p<0.05) increase of apoptosis (over 10% in MCF7 and about 5% in MDA-MB-231 cells, corresponding to the Annexin V assay) and DNA fragmentation (almost 30% in MCF7 and over 25% in MDA-MB-231 cells). Interestingly, also several proapoptotic genes were induced after the downregulation of the key telomerase subunit, including Bax, Bik or caspase-1 and caspase-14, as well as NGFR and TNFSF10 which were upregulated twice and more.

摘要

本研究旨在分析沉默编码端粒酶复合物关键亚基(即 TERT、TERC 和 TP1)的基因对人乳腺癌 MCF7 和 MDA-MB-231 细胞的影响。转染采用 Lipofectamine2000 和 Pooled siRNAs 进行。通过 SRB 测定、流式细胞术分析细胞周期和 TUNEL 分析检测 DNA 片段化来测量 siRNA 的细胞毒性和/或抗增殖作用。端粒酶活性通过 TRAP 评估,随后通过 PAGE 和 ELISA 测定。还使用 qPCR 评估端粒酶下调,以估计参与凋亡的基因表达谱的变化。结果表明,用不同的 siRNAs(100 nM)处理乳腺癌细胞会导致细胞类型和时间依赖性的影响。端粒酶亚基下调后,端粒酶活性降低至对照细胞的近 60%。然而,只有当 TERT 亚基下调时才会观察到显著的效果。其沉默导致凋亡显著增加(MCF7 中超过 10%,MDA-MB-231 细胞中约 5%,对应于 Annexin V 测定)和 DNA 片段化增加(MCF7 中近 30%,MDA-MB-231 细胞中超过 25%)。有趣的是,在关键端粒酶亚基下调后,还诱导了几种促凋亡基因,包括 Bax、Bik 或 caspase-1 和 caspase-14,以及 NGFR 和 TNFSF10,它们的上调倍数超过 2 倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc23/3723976/52e66aa5bb2a/11033_2013_2600_Fig1_HTML.jpg

相似文献

2
Riccardin D, a macrocyclic bisbibenzy, inhibits human breast cancer growth through the suppression of telomerase activity.
Basic Clin Pharmacol Toxicol. 2014 Dec;115(6):488-98. doi: 10.1111/bcpt.12267. Epub 2014 Jun 6.
4
Telomerase as a Possible Candidate Targeting Therapy in Different Breast Cancer Cell Lines.
Asian Pac J Cancer Prev. 2020 Aug 1;21(8):2243-2250. doi: 10.31557/APJCP.2020.21.8.2243.
8
Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
J Natl Cancer Inst. 2005 Dec 7;97(23):1746-59. doi: 10.1093/jnci/dji400.
9
Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
Breast Cancer. 2016 Mar;23(2):216-23. doi: 10.1007/s12282-014-0553-z. Epub 2014 Aug 7.

引用本文的文献

2
Beginning at the ends: telomere and telomere-based cancer therapeutics.
Mol Genet Genomics. 2024 Dec 6;300(1):1. doi: 10.1007/s00438-024-02206-6.
5
Multiple Actions of Telomerase Reverse Transcriptase in Cell Death Regulation.
Biomedicines. 2023 Apr 4;11(4):1091. doi: 10.3390/biomedicines11041091.
6
Activity in MCF-7 Estrogen-sensitive Breast Cancer Cells of Capsicodendrin from .
Anticancer Res. 2021 Dec;41(12):5935-5944. doi: 10.21873/anticanres.15412.
8
Telomerase as a Possible Candidate Targeting Therapy in Different Breast Cancer Cell Lines.
Asian Pac J Cancer Prev. 2020 Aug 1;21(8):2243-2250. doi: 10.31557/APJCP.2020.21.8.2243.
9
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.
Cells. 2019 Oct 8;8(10):1214. doi: 10.3390/cells8101214.

本文引用的文献

1
Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms.
Free Radic Biol Med. 2012;52(11-12):2234-45. doi: 10.1016/j.freeradbiomed.2012.03.014. Epub 2012 Apr 30.
2
Human telomerase expression regulation.
Biochem Cell Biol. 2011 Aug;89(4):359-76. doi: 10.1139/o11-037. Epub 2011 Jul 26.
3
Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo.
Oncol Rep. 2011 Oct;26(4):1019-27. doi: 10.3892/or.2011.1383. Epub 2011 Jul 8.
4
Histone deacetylase inhibition as an anticancer telomerase-targeting strategy.
Int J Cancer. 2011 Dec 15;129(12):2765-74. doi: 10.1002/ijc.26241. Epub 2011 Aug 8.
5
hTERT regulation by NF-κB and c-myc in irradiated HER2-positive breast cancer cells.
Int J Radiat Biol. 2011 Jun;87(6):609-21. doi: 10.3109/09553002.2011.572112.
6
High-mobility group A2 protein modulates hTERT transcription to promote tumorigenesis.
Mol Cell Biol. 2011 Jul;31(13):2605-17. doi: 10.1128/MCB.05447-11. Epub 2011 May 2.
7
p53 governs telomere regulation feedback too, via TRF2.
Aging (Albany NY). 2011 Jan;3(1):26-32. doi: 10.18632/aging.100271.
8
Inhibition of telomerase activity by HDV ribozyme in cancers.
J Exp Clin Cancer Res. 2011 Jan 6;30(1):1. doi: 10.1186/1756-9966-30-1.
9
Telomeres in cancer and ageing.
Philos Trans R Soc Lond B Biol Sci. 2011 Jan 12;366(1561):76-84. doi: 10.1098/rstb.2010.0291.
10
Human telomerase activity regulation.
Mol Biol Rep. 2011 Jun;38(5):3339-49. doi: 10.1007/s11033-010-0439-x. Epub 2010 Nov 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验